Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine
Authors:
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 23, 80-85
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s DiseasePLOS ONE, 2013
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseNeurology, 2012
- Trajectories of Depression Severity in Clinical Trials of DuloxetineArchives of General Psychiatry, 2011
- Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsBMC Neurology, 2010
- Trajectories of change in depression severity during treatment with antidepressantsPsychological Medicine, 2009
- Medication adherence and associated outcomes in medicare health maintenance organization‐enrolled older adults with Parkinson's diseaseMovement Disorders, 2007
- Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 yearsMovement Disorders, 2004
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960